home / stock / vlrx / vlrx news

VLRX News and Press, Valeritas Holdings From 11/12/19

Stock Information
Company Name: Valeritas Holdings
Stock Symbol: VLRX
Market: NASDAQ
Website: valeritas.com
Menu
VLRX VLRX Quote VLRX Short VLRX News VLRX Articles VLRX Message Board
Get VLRX Alerts

News, Short Squeeze, Breakout and More Instantly...
VLRX - Valeritas Holdings' (VLRX) CEO John Timberlake on Q3 2019 Results - Earnings Call Transcript

Valeritas Holdings, Inc. (VLRX) Q3 2019 Earnings Conference Call November 12, 2019 4:30 PM ET Company Participants Greg Chodaczek – Investor Relations John Timberlake – President and Chief Executive Officer Erick Lucera – Chief Financial Officer Conference...
VLRX - Valeritas EPS beats by $0.66, misses on revenue

Valeritas (NASDAQ: VLRX ): Q3 GAAP EPS of -$1.91 beats by $0.66 . More news on: Valeritas Holdings, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

VLRX - Valeritas Announces Third Quarter 2019 Financial Results

BRIDGEWATER, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced financi...

VLRX - NOV, XRX among premarket gainers

Amkor Technology (NASDAQ: AMKR ) +16%  on Q3 results . More news on: Amkor Technology, Inc., Mirati Therapeutics, Inc., Globus Maritime Limited, Stocks on the move, Read more ...

VLRX - Valeritas Presents Positive h-Patch(TM) Apomorphine Study Data at the World Congress of Neurology (WCN 2019)

BRIDGEWATER, N.J., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced positive data from its pr...

VLRX - Valeritas to Report Third Quarter 2019 Financial Results on November 12, 2019

BRIDGEWATER, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , today announced that it will release financ...

VLRX - GLP-1 Analogue Delivered Robustly via Subcutaneous Infusion with Valeritas Proprietary h-Patch(TM) Wearable Device in Preclinical Study

BRIDGEWATER, N.J., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses their proprietary h-Patch™ technology, announced today positive topline result...
VLRX - MNK, MCK among top premarket gainers

Viveve Medical (NASDAQ: VIVE ) +109%  on robust volume on no particular news. More news on: Viveve Medical, Inc., Achillion Pharmaceuticals, Inc., Ideal Power Inc., Stocks on the move, Read more ...

VLRX - Valeritas Presents Positive h-Patch(TM) Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer's Disease & Dementia

BRIDGEWATER, N.J., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced positive data from its pr...

VLRX - Valeritas Announces Poster Presentation of Preclinical h-Patch(TM) Cannabidiol (CBD) Study at the American Epilepsy Society's Annual Meeting

BRIDGEWATER, N.J., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced today a poster presentati...
Previous 10 Next 10